Less Ads, More Data, More Tools Register for FREE

The UK's Largest Investor Community

Indices

Indices Value Chg %
FTSE 10010,399.70 -108.91-1.04%
FTSE 25023,330.72 -34.01-0.15%
FTSE 3505,658.38 -53.81-0.94%
FTSE All-Share5,597.04 -52.65-0.93%
FTSE Small Cap7,918.11 -9.77-0.12%

Most Traded on Thursday 18th June

Company Price Value Trades
Shell (SHEL)2,962.00 £273,580.34k80,635
BP (BP.)490.05 £190,620.73k42,559
Rolls-Royce (RR.)1,409.60 £256,029.42k28,420
Rio Tinto (RIO)7,589.00 £244,764.41k19,554
Barclays (BARC)500.60 £326,671.29k19,103
Company Price Value Volume
Intertek Group (ITRK)5,815.00 £512,899.02k8,853,348
HSBC Holdings (HSBA)1,442.40 £448,441.81k31,328,890
National Grid (NG.)1,190.50 £341,950.41k28,690,744
Barclays (BARC)500.60 £326,671.29k65,648,153
Shell (SHEL)2,962.00 £273,580.34k9,404,368

Sector Activity

14:13

James Bruegger, CIO for Seraphim Space (SSIT); Why the SpaceX IPO changes everything for investors

The record-breaking IPO of SpaceX ( SPCX ) has thrust the commercial space sector firmly back into the spotlight, reigniting investor excitement around one of the fastest-evolving technology market...

03:23

What's Hot 16th June 2026

Will the promise of 'let the oil flow' become a platitude, will a billionaire's audacity be viewed as astute or retail hoarding and why might the UK market lose another cinematic experience? Sa...

00:47

Tap PLC: Tap Earn Update

Tap Global Group plc ( AIM: TAP ) has provided a further update on Tap Earn, its crypto yield product. Assets Under Management have surpassed US$5 million, representing 43% growth since May, driven...

Level 2 Order Book Level 2

The Level 2 Order Book shows what the market makers are doing – what price they are prepared to buy or sell at. The order book also shows whether there are more buy orders or sell orders and can indicate the next price movement.

Get Level 2 NOW

Featured Investment Trust

Polar Capital Global Healthcare Trust plc (PCGH)

As a specialist healthcare investment trust, PCGH focusses on powerful growth stories, from disruptive biotech to global pharmaceuticals. With a globally diversified approach, PCGH accesses multi-decade themes while expertly navigating near-term volatility with its bias to large, defensive companies.

Find Out More

Sign up to London South East Newsletters